Multicell Technologies Stock

Multicell Technologies Current Assets

The Current Assets of Multicell Technologies (MCET) as of Sep 5, 2026 is 125,900.00 USD. In the previous year, Current Assets was 178,800.00 USD — a change of -29.59% (lower).

Current Assets

125,900.00USD

YoY

-29.59%

Last updated:

Current Assets of Multicell Technologies is 2026 125,900.00 USD. Current Assets of Multicell Technologies was 2025 178,800.00 USD. It decreases by -29.59% lower compared to the previous year.

The Multicell Technologies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2007
500,000.00 USD
Jan 1, 2008
40,000.00 USD
Jan 1, 2009
403,000.00 USD
Jan 1, 2010
643,300.00 USD
Jan 1, 2011
415,900.00 USD
Jan 1, 2012
210,800.00 USD
Jan 1, 2013
178,800.00 USD
Jan 1, 2014
125,900.00 USD
The Multicell Technologies Current Assets history
YEARCurrent AssetsYoY
125,900.00USD-29.59%
178,800.00USD-15.18%
210,800.00USD-49.31%
415,900.00USD-35.35%
643,300.00USD+59.63%
403,000.00USD+907.50%
40,000.00USD-92.00%
500,000.00USD+257.14%
140,000.00USD-95.00%
2.80 MUSD+37.25%
2.04 MUSD+87.16%
1.09 MUSD+890.91%
110,000.00USD-78.43%
510,000.00USD-29.17%
720,000.00USD+800.00%
80,000.00USD+700.00%
10,000.00USD-50.00%
20,000.00USD-33.33%
30,000.00USD-90.32%
310,000.00USD+19.23%
260,000.00USD
Access this data via the Eulerpool API

Multicell Technologies Stock analysis

What does Multicell Technologies do? Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field. Multicell Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Multicell Technologies stock

Current Assets of Multicell Technologies is 125,900.00 USD in 2026.

Current Assets of Multicell Technologies changed from 178,800.00 USD to 125,900.00 USD, representing a -29.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Multicell Technologies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Multicell Technologies historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Multicell Technologies

All Key Metrics — Multicell Technologies